3.93
price up icon3.42%   0.13
after-market 시간 외 거래: 3.92 -0.01 -0.25%
loading
전일 마감가:
$3.80
열려 있는:
$3.78
하루 거래량:
274.37K
Relative Volume:
0.58
시가총액:
$228.78M
수익:
-
순이익/손실:
$-73.79M
주가수익비율:
-1.3838
EPS:
-2.84
순현금흐름:
$-77.44M
1주 성능:
+2.88%
1개월 성능:
+11.02%
6개월 성능:
-10.27%
1년 성능:
+123.30%
1일 변동 폭
Value
$3.73
$3.93
1주일 범위
Value
$3.56
$3.94
52주 변동 폭
Value
$1.35
$6.85

Pyxis Oncology Inc Stock (PYXS) Company Profile

Name
명칭
Pyxis Oncology Inc
Name
전화
(617) 221-9059
Name
주소
321 HARRISON AVENUE, BOSTON
Name
직원
55
Name
트위터
Name
다음 수익 날짜
2024-08-11
Name
최신 SEC 제출 서류
Name
PYXS's Discussions on Twitter

Pyxis Oncology Inc Stock (PYXS) Upgrades & Downgrades

날짜 액션 분석자 등급 변경
2021-11-02 개시 BofA Securities Neutral
2021-11-02 개시 Credit Suisse Outperform
2021-11-02 개시 Jefferies Buy

Pyxis Oncology Inc 주식(PYXS)의 최신 뉴스

pulisher
Nov 04, 2024

Pyxis Oncology, Inc. (NASDAQ:PYXS) Shares Bought by abrdn plc - MarketBeat

Nov 04, 2024
pulisher
Oct 24, 2024

Pyxis Oncology Inc (PYXS) Stock Price & Chart | Trade Now - Capital.com

Oct 24, 2024
pulisher
Oct 24, 2024

Pyxis Oncology, Inc. (NASDAQ:PYXS) Given Consensus Rating of "Buy" by Brokerages - MarketBeat

Oct 24, 2024
pulisher
Oct 24, 2024

Pyxis Oncology, Inc. (NASDAQ:PYXS) Receives Consensus Rating of “Buy” from Analysts - Defense World

Oct 24, 2024
pulisher
Oct 23, 2024

Pyxis Oncology expands equity plan by 5.5 million shares - Investing.com India

Oct 23, 2024
pulisher
Oct 18, 2024

Pyxis Oncology Q3 EPS Estimate Reduced by Leerink Partnrs - MarketBeat

Oct 18, 2024
pulisher
Oct 16, 2024

Financial Metrics Exploration: Understanding Pyxis Oncology Inc (PYXS) Through Ratios - The Dwinnex

Oct 16, 2024
pulisher
Oct 16, 2024

Examining Pyxis Oncology Inc (PYXS) stock is warranted - US Post News

Oct 16, 2024
pulisher
Oct 13, 2024

Millennium Management LLC Buys 743,499 Shares of Pyxis Oncology, Inc. (NASDAQ:PYXS) - MarketBeat

Oct 13, 2024
pulisher
Oct 02, 2024

Upward Trajectory: Pyxis Oncology Inc (PYXS) Posts a Slidee, Closing at 3.51 - The Dwinnex

Oct 02, 2024
pulisher
Sep 30, 2024

Pyxis Oncology's SWOT analysis: ADC developer's stock faces pivotal readout - Investing.com

Sep 30, 2024
pulisher
Sep 29, 2024

Rhumbline Advisers Takes Position in Pyxis Oncology, Inc. (NASDAQ:PYXS) - Defense World

Sep 29, 2024
pulisher
Sep 29, 2024

Pyxis Oncology, Inc. (NASDAQ:PYXS) Receives Average Recommendation of "Buy" from Analysts - MarketBeat

Sep 29, 2024
pulisher
Sep 28, 2024

Blue Owl Capital Holdings LP Purchases New Holdings in Pyxis Oncology, Inc. (NASDAQ:PYXS) - MarketBeat

Sep 28, 2024
pulisher
Sep 25, 2024

SHAREHOLDER ALERT: Levi & Korsinsky, LLP Notifies Shareholders of an Investigation Concerning Possible Breaches of Fiduciary Duty by Certain Officers and Directors of Pyxis Oncology, Inc. (NASDAQ:PYXS) - PR Newswire

Sep 25, 2024
pulisher
Sep 23, 2024

ShiftPixy stock plunges to 52-week low at $0.9 amid market challenges - Investing.com

Sep 23, 2024
pulisher
Sep 23, 2024

Prepare Yourself for Liftoff: Pyxis Oncology Inc (PYXS) - SETE News

Sep 23, 2024
pulisher
Sep 22, 2024

Pyxis Oncology, Inc. (NASDAQ:PYXS) Shares Bought by Bank of New York Mellon Corp - MarketBeat

Sep 22, 2024
pulisher
Sep 20, 2024

ShiftPixy, Inc. Announces Reverse Stock Split Effective Date - Business Wire

Sep 20, 2024
pulisher
Sep 20, 2024

Are Pyxis Oncology Inc’shares a good deal? - US Post News

Sep 20, 2024
pulisher
Sep 19, 2024

Pyxis Oncology (NASDAQ:PYXS) Receives "Outperform" Rating from Royal Bank of Canada - MarketBeat

Sep 19, 2024
pulisher
Sep 19, 2024

Market Insights: Pyxis Oncology Inc (PYXS)’s Notable Gain of 1.39, Closing at 3.66 - The Dwinnex

Sep 19, 2024
pulisher
Sep 17, 2024

Earth Science Tech (OTCMKTS:ETST) vs. Pyxis Oncology (NASDAQ:PYXS) Head-To-Head Comparison - Defense World

Sep 17, 2024
pulisher
Sep 13, 2024

Moment Of Truth Approaches For Pyxis Oncology (NASDAQ:PYXS) - Seeking Alpha

Sep 13, 2024
pulisher
Sep 06, 2024

Pyxis Oncology : Morgan Stanley 22nd Annual Global Healthcare Conference - Marketscreener.com

Sep 06, 2024
pulisher
Sep 04, 2024

Pyxis Oncology, Inc. (NASDAQ:PYXS) Receives Consensus Rating of "Buy" from Analysts - MarketBeat

Sep 04, 2024
pulisher
Sep 02, 2024

Pyxis Oncology Inc (PYXS) looking to reclaim success with recent performance - SETE News

Sep 02, 2024
pulisher
Sep 02, 2024

Have you been able to find a good deal on Pyxis Oncology Inc’s shares? - US Post News

Sep 02, 2024
pulisher
Aug 30, 2024

Quarterly Snapshot: Quick and Current Ratios for Pyxis Oncology Inc (PYXS) - The Dwinnex

Aug 30, 2024
pulisher
Aug 29, 2024

Pyxis Oncology to Participate in Two Upcoming Investor Conferences - GlobeNewswire

Aug 29, 2024
pulisher
Aug 27, 2024

JAZZ: 3 Oncology Stocks With Major Upside - StockNews.com

Aug 27, 2024
pulisher
Aug 21, 2024

PYXS Stock Earnings: Pyxis Oncology Misses EPS for Q2 2024 - MSN

Aug 21, 2024
pulisher
Aug 20, 2024

Market Momentum Report: Pyxis Oncology Inc (PYXS)’s Positive Close at 3.62 - The Dwinnex

Aug 20, 2024
pulisher
Aug 19, 2024

Q3 2024 EPS Estimates for Pyxis Oncology, Inc. Boosted by William Blair (NASDAQ:PYXS) - MarketBeat

Aug 19, 2024
pulisher
Aug 19, 2024

What is the investor’s view on Pyxis Oncology Inc (PYXS)? - US Post News

Aug 19, 2024
pulisher
Aug 19, 2024

Cetera Advisors LLC Makes New $100,000 Investment in Pyxis Oncology, Inc. (NASDAQ:PYXS) - Defense World

Aug 19, 2024
pulisher
Aug 19, 2024

Q3 2024 Earnings Estimate for Pyxis Oncology, Inc. (NASDAQ:PYXS) Issued By William Blair - Defense World

Aug 19, 2024
pulisher
Aug 18, 2024

Vanguard Group Inc. Acquires 94,740 Shares of Pyxis Oncology, Inc. (NASDAQ:PYXS) - Defense World

Aug 18, 2024
pulisher
Aug 16, 2024

Pyxis Oncology's (PYXS) "Buy" Rating Reiterated at HC Wainwright - MarketBeat

Aug 16, 2024
pulisher
Aug 16, 2024

Pyxis Oncology maintains steady target with Buy rating from H.C. Wainwright - Investing.com India

Aug 16, 2024
pulisher
Aug 16, 2024

Market Insight: Pyxis Oncology Inc (PYXS)’s Notable Gain, Closing at 3.43 - The Dwinnex

Aug 16, 2024
pulisher
Aug 16, 2024

Pyxis Oncology (NASDAQ:PYXS) Earns “Buy” Rating from HC Wainwright - Defense World

Aug 16, 2024
pulisher
Aug 14, 2024

Pyxis Oncology Provides Corporate Update and Reports Financial Results for Second Quarter 2024 - GlobeNewswire

Aug 14, 2024
pulisher
Aug 10, 2024

Analysts Set Pyxis Oncology, Inc. (NASDAQ:PYXS) PT at $9.00 - MarketBeat

Aug 10, 2024
pulisher
Aug 10, 2024

Pyxis Oncology, Inc. (NASDAQ:PYXS) Given Consensus Recommendation of “Buy” by Analysts - Defense World

Aug 10, 2024
pulisher
Aug 08, 2024

Pyxis Oncology stock gains as Stifel says buy (NASDAQ:PYXS) - Seeking Alpha

Aug 08, 2024
pulisher
Aug 08, 2024

Pyxis Oncology (NASDAQ:PYXS) Earns Buy Rating from Analysts at Stifel Nicolaus - MarketBeat

Aug 08, 2024
pulisher
Aug 08, 2024

What was Pyxis Oncology Inc (PYXS)’s performance in the last session? - US Post News

Aug 08, 2024
pulisher
Aug 07, 2024

Stifel sets $10 target on Pyxis Oncology, cites unique approach - Investing.com

Aug 07, 2024
pulisher
Aug 07, 2024

Market Recap Check: Pyxis Oncology Inc (PYXS)’s Positive Finish at 3.37, Up/Down 3.69 - The Dwinnex

Aug 07, 2024
pulisher
Aug 06, 2024

Pyxis Oncology Insider Stock Sellers Must Be Relieved As Market Cap Falls To US$203m - Simply Wall St

Aug 06, 2024

Pyxis Oncology Inc (PYXS) 재무 분석

매출

loading

순이익

loading

현금흐름

loading

주당 순 이익

loading
$77.28
price up icon 2.02%
$20.39
price up icon 2.15%
$382.77
price up icon 1.58%
$53.29
price down icon 0.47%
$208.03
price up icon 0.38%
$110.97
price up icon 1.84%
자본화:     |  볼륨(24시간):